Categories: News

Stryker Launches State-of-the-art Neurovascular R&D Lab with Advanced Technology to Accelerate Stroke Care Innovation

Published by
News Voir

Stryker, one of the world’s leading medical technology companies, recently opened its Neurovascular (NV) lab, a state-of-the-art lab designed to accelerate stroke-related innovation in Asia Pacific. Located within the Stryker Global Technology Center (SGTC) at International Park, Gurgaon, India, the Keystone Suite will enable collaboration between customers, product development engineers, cross-functional teams, and other key stakeholders.

Stryker inaugurates its state-of-the-art neurovascular R&D Lab in Gurgaon

Stroke is a leading cause of death and disability worldwide, with more than 58 million of those cases recorded in Asia1. In India, scarcity of professional care and infrastructure are key factors in the country’s treatment rates. This lab offers an ideal environment for medical education, research and development, and customer engagement activities designed to improve patient outcomes.

The NV lab has three main components: a neurovascular catheterization lab designed to mimic the hospital treatment experience with the latest imaging and communication equipment; a performance lab with hands-on stations outfitted with flow models, neurovascular simulators and 3D model printing capabilities; and planned space for physician interaction.

Mark O’Brien, Vice President and General Manager for the Neurovascular Division at Stryker, said, “Asia Pacific is our fastest growing region, and a big part of our future growth plans. We are continuing to invest in the region to facilitate innovation and advance stroke care.”

Ram Rangarajan, Vice President of Stryker Global Technology Center, said, “We’re excited to bring this advanced lab and its capabilities to India’s neurointerventionalist community and to help grow the specialty in country. We believe in the concept of public-private partnerships and invite the government to collaborate with us to train future physicians.”

Stryker established its first R&D facility in India more than 15 years ago to provide engineering support to R&D functions in domestic and other emerging markets. Today the center has over 1,000 employees and is one of the company’s leading strategic innovation hubs. The new SGTC facility furthers Stryker’s commitment to India and recognizes its robust ecosystem of world-class research, medical technology innovation capability and talent expertise landscape.

News Voir

Recent Posts

Miner Orb Introduces a New, Secure Way of

Nevada, Texas, United States, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Summary: Miner Orb has emerged as… Read More

26 mins ago

Bioasis Announces AGM Results and Provides Update on


27 mins ago

KBRA Assigns Preliminary Ratings to LAD Auto Receivables Trust 2023-1

NEW YORK--(BUSINESS WIRE)--#KBRA--KBRA assigns preliminary ratings to six classes of notes issued by LAD Auto… Read More

28 mins ago

AERWINS Technologies Inc. and PONO Capital Corp. Complete

HONOLULU and TOKYO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- AERWINS Technologies Inc. (“AERWINS” or the… Read More

1 hour ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals,… Read More

1 hour ago

Sarissa Capital Highlights Amarin’s Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at Amarin

Sarissa launches website and posts presentation for shareholders Sarissa urges shareholders to vote the… Read More

1 hour ago